The trial of Dolin v. Smithkline Beecham Corp. (also known as GlaxoSmithKline or GSK) began in March of 2017 in Chicago, Illinois. Plaintiff Wendy Dolin filed the lawsuit against GSK in 2012 over the alleged paroxetine-induced wrongful death of her late husband, Stewart Dolin, who was a partner at the law firm Reed Smith.
Stewart Dolin began taking paroxetine in July of 2010. Paxil, the brand name version of generic paroxetine, was researched, developed, manufactured and marketed by GSK. Paxil and paroxetine are the same chemical compound and share the same product labeling. GSK created and was responsible for maintaining the accuracy of the Paxil label.
In the early afternoon on July 15, 2010, Stewart Dolin walked to a Chicago Transit Authority station shortly after a business lunch with a colleague. A woman at the station noticed that Mr. Dolin was pacing and appeared to be agitated as he looked in the direction of an approaching train that was not yet in sight. When the moving train appeared, the woman observed Mr. Dolin leap in front of the train, where he was struck. Ultimately, Mr. Dolin was pronounced dead from the injuries he suffered due to the collision and his contact with the electrified track after the collision.
Per the lawsuit allegations, GSK failed to adequately warn Mr. Dolin’s doctor about Paxil/paroxetine’s association with an increased risk of suicidal behavior in adults of all ages. The Court previously ruled that, although GSK did not manufacture the pills Mr. Dolin ingested, the company was responsible for the label and knew or should have known any failure to warn would result in harm to those taking generic versions of the drug.
Plaintiff’s Exhibit 347: Each picture depicts a real person who committed suicide while taking Paxil in a GSK-clinical trial. The red “Vs” mean their specific suicides were violent in nature. There were multiple suicides using firearms, including a murder suicide by one patient. There were also two deaths from people jumping in front of trains.
When it comes to suicide attempts, GSK did not keep track of all the attempted suicides in their clinical trials because, according to their company witness, it would be too burdensome.